Jump to Navigation

User login

Facebook Connect

NLA Meetings

Meeting Info

NLA Clinical Lipid Update – Fall 2014

Indianapolis, IN
Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners and registered dietitians with an interest in lipid management.

Type of Activity
Live Activity; Application (Sessions I, IV-V, IX), Knowledge (Keynote lecture, Special Sessions New Lipid Guidelines Perspectives & Vulnerable Blood, Sessions II-III, VI-VIII)

You can view NLA Meeting Highlights from previous confereces.

Pre-Conference Courses:
Coming soon

More information is coming soon...

Plan now for your company to participate in the National Lipid Association’s premier scientific meeting series in 2014. Our meetings provide you with a unique opportunity to reach our target audience of Lipidologists, Cardiologists, Endocrinologists, Primary Care Physicians and Allied Health Professionals involved in dyslipidemia management, as well as our distinguished board and faculty.

Our numerous sponsorship opportunities allow you to connect with our members in a whole new way, providing you with maximum return on your investment. The exhibit hall provides a unique setting for you and your company’s representatives to interact daily with attendees as they study the latest advances in their professions. Exhibiting in Hawaii is an excellent way to showcase your commitment to the NLA. You may take these opportunities to acquaint the attendees with the benefits of your products and services in an intimate setting.

If you are interested in becoming a grant supporter or have any questions regarding exhibit opportunities, please contact the Event Department directly, contact info below.

The Fall Clinical Lipid Update Exhibit Prospectus




Contact Info:
Theresa Henson
Event Coordinator


More information is coming soon.

More information is coming soon...

More information is coming soon...


The National Lipid Association (NLA) has established that independently developed and CME/CE certified satellite symposia held in conjunction with the scientific meetings of the NLA are valuable opportunities to provide continuing education for our members. In this regard, we are pleased to offer satellite symposia slots in conjunction with our 2014 NLA Meeting Series.
Satellite symposia are non-commercial CME- and CE-certified activities addressing educational needs and performance gaps that complement the NLA scientific program agenda. They may include one or a number of speakers and may cover one or several topics addressing the educational gaps of lipid specialists.
The following deadlines and guidelines provide important information about holding a
satellite symposium at an NLA meeting and the process for completing a symposium proposal. Please contact the NLA business development department directly (contact below) should there be any questions or further information required. See you in 2014!




Amina Resheidat
Program Coordinator


No votes yet

Saturday, March 15
Workshop 1: Lipids on the Front Lines
12:45 - 1:15 PM Interpreting results: is There a Role for Advanced Lipid Testing? Elizabeth J. Jackson, MSN, CNS, CLS, FNLA
1:15 - 1:45 PM Navigating Around the Roadblocks: Lipid Management, Barriers and Byways Randy W. Burden, PharmD, MDiv, PhC, CLS, FNLA
1:45 - 2:15 PM Cardiometabolic Benefits of Low - Intensity Physical Activity Marc Hamilton, PhD
2:15 - 2:45 PM Case Study Wrap Up and Q&A  


Workshop 2: Lipid Science and Research
12:45 - 1:15 PM How do we Avoid Faltering in Design of Clinical Trials? Eliot Brinton, MD, FNLA*
1:15 - 1:45 PM Should we Change the Endpoints in Cardiovascular Research Outcomes? Sekar Kathiresan, MD
1:45 - 2:15 PM Framingham and Beyond: Lessons Learned and Future Needs from Key Epidemiologic Studies Nathan D. Wong, PhD
2:15 - 2:45 PM Case Study Wrap Up and Q&A  


Please select one workshop. Workshop included in your registration.

Monoclonal Antibodies (mAbs): Three Decades of Innovation and Progress

May 2, 2014 at 12:00-1:00PM


Eli M. Roth MD, FACC, FNLA

Medical Director, Sterling Research Group

Professor of Clinical Medicine, University of Cincinnati

Grand Cypress Ballroom G


Brought to you by Sanofi-aventis U.S. and Regeneron Pharmaceuticals, Inc.

No votes yet

by Dr. Radut.